Overview

A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer

Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to evaluate the use of two medications, docetaxel and lovastatin to determine the highest dose of lovastatin and docetaxel that can be given safely as well as the safety of combining the two drugs and the effect on the subject's tumor. Subjects can have any cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Susan L Roeder
University of Iowa
Treatments:
Dihydromevinolin
Docetaxel
L 647318
Lovastatin